Momentum Watch: Hemispherx Biopharma (HEB) Spotted Above Chikou

At current levels, Hemispherx Biopharma (HEB) is trading on top of the Chikou. If the stock continues to stay above the line, traders might be anticipating a possible upward momentum swing.

Investors might be looking to rebuild the portfolio as we move into the second half of the year. New investors can be tempted to try to maximize returns by owning one specific sector or be exposed to a fairly large single investment. By diversifying the portfolio, investors might be able to protect themselves from a sudden move against the position. Finding the correct portfolio balance is how many investors choose to approach the markets. This may take some time to master, and there may be some bumps along the way. Investors managing their own money may want to make sure that they know exactly what stocks are in the portfolio at all times. Keeping tabs on portfolio performance can also be a good way to make sure that it is weighted properly.

Technical analysts have been monitoring shares of Hemispherx Biopharma (HEB) as of late. The Relative Strength Index (RSI) is one of multiple popular technical indicators created by J. Welles Wilder. Wilder introduced RSI in his book “New Concepts in Technical Trading Systems” which was published in 1978. RSI measures the magnitude and velocity of directional price movements. The data is represented graphically by fluctuating between a value of 0 and 100. The indicator is computed by using the average losses and gains of a stock over a certain time period. RSI can be used to help spot overbought or oversold conditions. An RSI reading over 70 would be considered overbought, and a reading under 30 would indicate oversold conditions. A level of 50 would indicate neutral market momentum. Presently, the 14-day RSI is standing at 38.55, the 7-day is 33.32, and the 3-day is resting at 13.65.

Taking a look at the numbers, Hemispherx Biopharma (HEB) has a 14-day Commodity Channel Index (CCI) of -116.27. The CCI technical indicator can be used to help determine if a stock is overbought or oversold. CCI may also be used to help discover divergences that could possibly signal reversal moves. A CCI closer to +100 may provide an overbought signal, and a CCI near -100 may offer an oversold signal.

Currently, the 14-day ADX for Hemispherx Biopharma (HEB) is sitting at 27.96. Generally speaking, an ADX value from 0-25 would indicate an absent or weak trend. A value of 25-50 would support a strong trend. A value of 50-75 would identify a very strong trend, and a value of 75-100 would lead to an extremely strong trend. ADX is used to gauge trend strength but not trend direction. Traders often add the Plus Directional Indicator (+DI) and Minus Directional Indicator (-DI) to identify the direction of a trend.

Checking in on moving averages, the 200-day is at 0.22, the 50-day is 0.18, and the 7-day is sitting at 0.15. Moving averages may be used by investors and traders to shed some light on trading patterns for a specific stock. Moving averages can be used to help smooth information in order to provide a clearer picture of what is going on with the stock. Technical stock analysts may use a combination of different time periods in order to figure out the history of the equity and where it may be headed in the future. MA’s can be calculated for any time period, but two very popular time frames are the 50-day and 200-day moving averages.

With the stock market continuing to move higher, investors may be searching for stocks that are still fairly undervalued. This may involve doing a little bit more homework than usual. Spotting those names that have been cast aside and not garnering much recent attention might be a good place to start. Putting in a few extra hours of stock research may provide some good options for buying on the next big dip. Of course, nobody can say for sure how long the markets will continue to climb. Being ready for a pullback can help if investors already have some names in mind that they are looking to scoop up when they fall to a certain level. Tracking the technicals and staying up on the fundamentals should help investors hone in on the next wave of stocks to add to the portfolio.